WE CONTINUE THE CAMPAIGN FOR PFIZER TO ALLOW THE DISTRIBUTION OF...
Paxlovid helps prevent #PERSISTENTCOVID and reduces hospitalization of older adults by 85%. But the pharmaceutical company does not allow the distribution of generics. Let...
NGO INNOVARTE meets with Director of the Executive Office of Technology...
This Friday, December 16th, 2022, Luis Villarroel, Director of NGO INNOVARTE, Mariana Fernandez, Lawyer of NGO INNOVARTE and Javier Llamoza of AIS Peru, met...
NGO INNOVARTE meets with Pontifical Catholic University of Perú to present...
On December 19th, 2022, Mariana Fernandez, lawyer of NGO INNOVARTE, and Javier Llamoza of AIS Peru, met with Dr. Sandra Perez Buitrago of the...
WE CONTINUE CAMPAIGNING FOR PFIZER TO ALLOW DISTRIBUTION OF GENERIC DRUGS
NGO Innovarte (Chile) AIS (Peru) and other non-profit organizations, we request Pfizer to end its monopoly on the antiviral drug Paxlovid™ and allow the...
NGO INNOVARTE submits letter to Ministries of Health of Chile and...
In order to promote the use of platforms such as WHO's C-TAP
On December 21st, 2022, NGO INNOVARTE submitted a letter to the Ministries of...
NGO INNOVARTE SENDS LETTER TO THE MINISTRY OF HEALTH OF URUGUAY
Last December 21st, 2022, NGO INNOVARTE sent a letter to the Ministry of Uruguay as a follow-up to the last one sent in October...
Free Competition and Digital Platforms Newsletter VI
We are pleased to publish the sixth edition of the Free Competition and Digital Platforms Newsletter prepared by NGO INNOVARTE with the Pro Bono...
PAXLOVID™ generic receives WHO endorsement
A new reason for the Ministry of Health and Pfizer to authorize the distribution of PAXLOVID™ generics in Chile, amid growing international concern about...
NGO INNOVARTE AND AIS PERU SEND LETTER TO THE MINISTER OF...
On December 29th, 2022, AIS Peru and NGO INNOVARTE sent a letter to Dr. Rosa Gutierrez Palomino, Minister of Health of Peru, highlighting the...
